Sun Pharma Advanced Research Company informs about company updates

09 Dec 2019 Evaluate

Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015 and further to letter No. SPARC/Sec/SE/2019-20/027 dated 20th August 2019, Sun Pharma Advanced Research Company has informed that, Abraxis Biosciences LLC has dismissed the patent infringement complaint filed against SPARC regarding SPARCs New Drug Application for PICS (Paclitaxel Injection Concentrate for Suspension).

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

135.20 0.75 (0.56%)
01-Jan-2026 10:27 View Price Chart
Peers
Company Name CMP
Syngene Internation. 643.15
Indegene 519.45
CMS Info Systems 342.00
Sagility 51.54
Smartworks Coworking 494.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×